Takeda Pharmaceutical Co Ltd (TAK) insider trading
Every open-market stock purchase and sale by Takeda Pharmaceutical Co Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Andrew Stewart Plump (President) and 1 other sold $2.8M in the last 90 days.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $2.8M (2 sales). Last close $19.05 on Sep 17, 2026.
Recent TAK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | Lauren Rusckowski Duprey (C-suite exec) | Sold | $640K |
| Sep 2, 2026 | Andrew Stewart Plump (President) | Sold | $2.1M |
| Jul 10, 2026 | Milano Furuta (CFO) | Sold (not open market) | $82M |
| Jul 10, 2026 | Miki Tsusaka (Director) | Sold (not open market) | $10.6M |
| Jul 10, 2026 | Masami Iijima (Director) | Sold (not open market) | $10.6M |
| Jul 10, 2026 | John Maraganore (Director) | Sold (not open market) | $5.7M |
| Jul 10, 2026 | Steven Gillis (Director) | Sold (not open market) | $5.7M |
| Jul 10, 2026 | Kimberly A. Reed (Director) | Sold (not open market) | $5.7M |
| Jul 10, 2026 | Asuka Miyabashira (President) | Sold (not open market) | $5M |
| Jul 1, 2026 | Nicola Deidre Petal Greenway (Officer) | Bought (not open market) | — |
| Jul 1, 2026 | Awny Samaan Botros Farajallah (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Natalie Anne Marie Furney (General Counsel) | Bought (not open market) | — |
| Jul 1, 2026 | Gabriele Ricci (Officer) | Bought (not open market) | — |
| Jul 1, 2026 | Elaine Mary Shannon (Officer) | Bought (not open market) | — |
| Jul 1, 2026 | Lauren Rusckowski Duprey (C-suite exec) | Bought (not open market) | — |
| Jul 1, 2026 | Teresa Marie Bitetti (President) | Bought (not open market) | — |
| Jul 1, 2026 | Julie So-Young Kim (CEO) | Bought (not open market) | — |
| Jul 1, 2026 | Julie So-Young Kim (CEO) | Bought (not open market) | — |
| Jul 1, 2026 | Steven Gillis (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Steven Gillis (Director) | Bought (not open market) | — |
| Jul 1, 2026 | John Maraganore (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Kimberly A. Reed (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Kimberly A. Reed (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Masami Iijima (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Masami Iijima (Director) | Bought (not open market) | — |
Who's trading TAK
- Lauren Rusckowski Duprey, C-suite exec: sold $640K (1 sale), last Sep 14, 2026
- Andrew Stewart Plump, President: sold $2.1M (1 sale), last Sep 2, 2026
- Kimberly A. Reed, Director: other filings, last Jul 10, 2026
- John Maraganore, Director: other filings, last Jul 10, 2026
- Asuka Miyabashira, President: other filings, last Jul 10, 2026
- Milano Furuta, CFO: other filings, last Jul 10, 2026
- Masami Iijima, Director: other filings, last Jul 10, 2026
- Miki Tsusaka, Director: other filings, last Jul 10, 2026
- Steven Gillis, Director: other filings, last Jul 10, 2026
- Agosti Marcello Pignagnoli, Officer: other filings, last Jul 1, 2026
- Giles Richard Platford, President: other filings, last Jul 1, 2026
- Gabriele Ricci, Officer: other filings, last Jul 1, 2026
- Elaine Mary Shannon, Officer: other filings, last Jul 1, 2026
- Jennifer Marie Smoter, Officer: other filings, last Jul 1, 2026
- Paulus Stoffels, Director: other filings, last Jul 1, 2026
Get free alerts when an insider at Takeda Pharmaceutical Co Ltd files a new trade →